Novartis Investigative Site

St Albans, Victoria 3021

0 studies enrolling now · 5 studies all time

What they study most

Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Focal Segmental Glomerulosclerosis, IgA Nephropathy, Immunoglobulin A Nephropathy, Sarcopenia

Studies at this site

• Atrasentan in Patients With Proteinuric Glomerular Diseases — Running, not enrolling
• A Study of Zigakibart in Adults With IgA Nephropathy — Running, not enrolling
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed
• Dose Range Finding Study of Bimagrumab in Sarcopenia — Completed
• A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study — Completed